In addition, both TNF and IFN-γ are elevated in patients with COVID-19, and preclinical studies have suggested combined inhibition of TNF and IFN-γ signaling can decrease the effects of cytokine storm driven by PANoptosis (Fig. 3) [5, 12, 160]. The gene discussed is IFNG; the disease is COVID-19.